X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2480) 2480
Publication (188) 188
Book Review (60) 60
Magazine Article (20) 20
Newsletter (20) 20
Book / eBook (15) 15
Book Chapter (8) 8
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1232) 1232
index medicus (1059) 1059
animals (895) 895
quinolones (816) 816
male (610) 610
pharmacology & pharmacy (607) 607
fluoroquinolones (540) 540
quinolones - pharmacology (531) 531
female (526) 526
ciprofloxacin (390) 390
antibiotics (332) 332
quinolones - therapeutic use (322) 322
mice (293) 293
chemistry, medicinal (282) 282
rats (272) 272
adult (259) 259
quinolones - administration & dosage (256) 256
quinolones - toxicity (249) 249
analysis (247) 247
microbiology (242) 242
middle aged (241) 241
quinolone antibacterial agents (236) 236
dose-response relationship, drug (234) 234
quinolones - chemistry (234) 234
quinolone (224) 224
toxicology (220) 220
anti-bacterial agents - pharmacology (213) 213
toxicity (209) 209
oncology (207) 207
aged (206) 206
biochemistry & molecular biology (205) 205
structure-activity relationship (203) 203
microbial sensitivity tests (201) 201
quinolones - adverse effects (199) 199
in-vitro (185) 185
research (181) 181
infectious diseases (179) 179
quinolones - pharmacokinetics (174) 174
pharmacokinetics (170) 170
cancer (165) 165
drug therapy (161) 161
anti-infective agents - toxicity (160) 160
administration, oral (153) 153
anti-infective agents - pharmacology (150) 150
drugs (140) 140
health aspects (140) 140
antibacterial agents (137) 137
molecular structure (133) 133
treatment outcome (133) 133
ofloxacin (132) 132
levofloxacin (129) 129
cell line, tumor (125) 125
chemistry, organic (123) 123
escherichia-coli (121) 121
quinolones - chemical synthesis (120) 120
antineoplastic agents - pharmacology (119) 119
anti-bacterial agents - chemistry (117) 117
bacteria (117) 117
dosage and administration (116) 116
drug interactions (116) 116
care and treatment (115) 115
rats, sprague-dawley (111) 111
derivatives (110) 110
fluoroquinolone (110) 110
anti-bacterial agents - therapeutic use (109) 109
resistance (109) 109
medicine & public health (107) 107
article (106) 106
drug resistance in microorganisms (106) 106
apoptosis (104) 104
environmental sciences (103) 103
chemistry, multidisciplinary (102) 102
drug resistance (102) 102
pharmacology/toxicology (102) 102
anti-infective agents - pharmacokinetics (101) 101
agents (99) 99
pharmacology (99) 99
therapy (99) 99
anti-infective agents - therapeutic use (98) 98
time factors (94) 94
chemotherapy (93) 93
anti-infective agents - administration & dosage (92) 92
dna gyrase (92) 92
adolescent (91) 91
child (91) 91
aripiprazole (90) 90
cells, cultured (89) 89
antibacterial activity (88) 88
cytotoxicity (88) 88
aged, 80 and over (87) 87
anti-infective agents - adverse effects (87) 87
antimicrobial agents (86) 86
antineoplastic agents - therapeutic use (85) 85
cell survival - drug effects (85) 85
dna (84) 84
fluoroquinolones - pharmacology (82) 82
internal medicine (82) 82
risk factors (82) 82
norfloxacin (81) 81
infections (80) 80
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2496) 2496
Japanese (22) 22
French (14) 14
German (5) 5
Spanish (5) 5
Bulgarian (1) 1
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Italian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0179254
Objectives The study aim was to evaluate the impact on Liver and Kidney toxicity of the single tablet regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir... 
REVERSE-TRANSCRIPTASE INHIBITOR | PATIENT-REPORTED SYMPTOMS | COFORMULATED ELVITEGRAVIR | MULTIDISCIPLINARY SCIENCES | NON-INFERIORITY TRIAL | CO-FORMULATED ELVITEGRAVIR | INITIAL TREATMENT | OPEN-LABEL | HIV-1 INFECTION | BOOSTED PROTEASE INHIBITOR | PHASE 3B | Emtricitabine - therapeutic use | Tenofovir - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Humans | Middle Aged | Male | Maximum Tolerated Dose | Quinolones - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Cobicistat - therapeutic use | Safety | Drug Combinations | Antiviral agents | Complications and side effects | Dosage and administration | Kidney failure | Research | Risk factors | Slopes | Therapy | Toxicity | Liver | Transaminase | Chronic infection | Viruses | Infections | Tenofovir | Ethics | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Quality | Human immunodeficiency virus--HIV | Emtricitabine | Antiretroviral drugs | Alanine | Filtration | Kidneys | Epidermal growth factor receptors | Patients | Antiretroviral therapy | Glomerular filtration rate | Studies | Infectious diseases | Hospitals | Surveillance | Alanine transaminase | Aspartate aminotransferase | Kidney transplantation | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
BMC VETERINARY RESEARCH, ISSN 1746-6148, 06/2019, Volume 15, Issue 1, pp. 209 - 209
BackgroundWhile commercial poultry and captive birds are exposed to antimicrobials through direct medication, environmental pollution may result in... 
Hatchability | Marbofloxacin | PHARMACEUTICALS | Avian embryonic heart rate | Pre-term hatching | ORGANOCHLORINES | ANTIBIOTIC-RESIDUES | TRENDS | Enrofloxacin | EGGS | Reproduction | Antibiotics | BROMINATED FLAME RETARDANTS | WILDLIFE | VETERINARY SCIENCES | NESTLINGS | EXPOSURE | Control | Usage | Bacterial infections | Birds | Quinolone antibacterial agents | Research | Quinolones
Journal Article
Journal of Environmental Management, ISSN 0301-4797, 05/2017, Volume 193, pp. 439 - 447
Antimicrobials are continuously detected in environmental waters and their removal is important to avoid health and microorganisms damage. In this work, the... 
Antimicrobial activity | Photolysis | Ofloxacin | Advanced oxidation process | Peroxidation | Sulfaquinoxaline | PHARMACEUTICALS | OXIDATION PROCESSES | SPECTROPHOTOMETRIC DETERMINATION | DEGRADATION KINETICS | MASS-SPECTROMETRY | EMERGING CONTAMINANTS | ENVIRONMENTAL SCIENCES | PHOTO-FENTON | WASTE-WATER | QUINOLONE ANTIBACTERIALS | Index Medicus
Journal Article
Journal of Hazardous Materials, ISSN 0304-3894, 07/2015, Volume 292, pp. 34 - 43
The continuous ozonation of the antibiotic ofloxacin (OFX) has been performed using a synthetic water matrix and in a sewage treatment plant (STP) effluent.... 
Continuous ozonation | STP effluent | Quinolone antibiotic | Biotest battery | Reaction pathway | Water Pollutants, Chemical - chemistry | Ofloxacin - chemistry | Anti-Bacterial Agents - chemistry | Ozone - chemistry | Ofloxacin | Ozonization | Index Medicus | Toxicology | Toxic | Toxicity | Algae | Effluents | Bacteria | Organisms | Transformations
Journal Article
Environmental Pollution, ISSN 0269-7491, 11/2019, Volume 254, Issue Pt B, p. 112861
As a new type of pollutant, fluoroquinolones (FQs) antibiotics are ubiquitous in environment and have some threat to human health and ecological environment.... 
Zebrafish | Ciprofloxacin | Gatifloxacin | Cardiovascular toxicity | Environmental risk | DANIO-RERIO | PHARMACEUTICALS | PERSISTENCE | QUINOLONE | HEART | ENVIRONMENTAL SCIENCES | DRUGS | FLUOROQUINOLONE ANTIBIOTICS | ENROFLOXACIN | AGENTS | WATER
Journal Article
JOURNAL OF HAZARDOUS MATERIALS, ISSN 0304-3894, 07/2015, Volume 292, pp. 34 - 43
The continuous ozonation of the antibiotic ofloxacin (OFX) has been performed using a synthetic water matrix and in a sewage treatment plant (STP) effluent.... 
OXIDATION | OZONATED WASTE-WATER | Continuous ozonation | STP effluent | ACTIVATED-SLUDGE | ANTIBIOTIC-RESISTANT BACTERIA | ENVIRONMENT | Quinolone antibiotic | AQUEOUS-SOLUTION | ENVIRONMENTAL SCIENCES | VIBRIO-FISCHERI | ENGINEERING, ENVIRONMENTAL | TREATMENT PLANTS | Reaction pathway | GENES | OZONE | Biotest battery
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2011, Volume 651, Issue 1-3, pp. 73 - 76
Journal Article